The bZip dimerization domain of the Epstein-Barr virus BZLF1 (Z) protein mediates lymphoid-specific negative regulation

Virology

Volumn 229, Issue 1, 1997, Pages 36-48

  Hong, Yu ^a   Holley Guthrie, Elizabeth ^a   Kenney, Shannon ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN CELL; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS CELL INTERACTION; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 0031550772     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8413     Document Type: Article

References (55)

1. Artandi, S., and Calame, K. (1993). Glutathione S-transferase fusion protein affinity chromatography to assess biochemical interactions between DNA-binding proteins. In "Methods in Molecular Genetics" (K. W. Adolph, Ed.), pp. 267-279. Academic Press, San Diego, CA.
2. Baeuerle, P. A. (1991). The inducible transcription activator NF-kappa B: Regulation by distinct protein subunits. Biochem. Biophys. Acta 1072, 63-80.
3. Baeuerle, P. A., and Baltimore, D. (1988). IκB: A specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
4. Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A., and Baldwin, A. S. (1992). IκB interacts with the nuclear localization sequences of the subunits of NF-κB: A mechanism for cytoplasmic retention. Genes Dev. 6, 1899-1913.
5. Chang, Y., Dong, D., Hayward, G., and Hayward, S. D. (1990). The Epstein-Barr virus Zta transactivator: A member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J. Virol. 64, 3358-3369.
6. Chevallier-Greco, A., Gruffat, H., Manet, E., Calender, A., and Sergeant, A. (1989). The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: Domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. J. Virol. 63, 615-623.
7. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J., and Sergeant, A. (1986). Both Epstein-Barr virus (EBV) encoded transacting factors, EB1 and EB2, are required to activate transcription from an early EBV promoter. EMBO J. 5, 3243-3249.
8. Chi, T., Lieberman, P., Ellwood, K., and Carey, M. (1995). A general mechanism for transcriptional synergy by eukaryotic activators. Nature (London) 377, 254-257.
9. Countryman, J., and Miller, G. (1985). Activation of expression of latent Epstein-Barr virus after gene transfer with a small cloned fragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA 82, 4085-4089.
10. Cox, M., Leahy, J., and Hardwick, J. M. (1990). An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J. Virol. 64, 313-321.
11. Farrell, P., Rowe, D., Rooney, C., and Kouzarides, T. (1989). Epstein-Barr virus BZLF1 trans-activator specifically binds to consensus Ap1 site and is related to c-fos. EMBO J. 8, 127-132.
12. Fixman, E., Hayward, G., and Hayward, S. D. (1995). Replication of Epstein-Barr virus oriLyt: Lack of a dedicated virally encoded origin-binding protein and dependence on Zta in co-transfection assays. J. Virol. 69, 2998-3006.
13. Flemington, E., and Speck, S. H. (1990). Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64, 1227-1232.
14. Flemington, E., and Speck, S. H. (1991). Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc. Natl. Acad. Sci. USA 87, 9459-9463.
15. Flemington, E., Goldfeld, A. E., and Speck, S. H. (1991). Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J. Virol. 65, 7073-7077.
16. Flemington, E., Lytle, J., Cayrol, C., Borras, A., and Speck, S. (1994). DNA-binding-defective mutants of the Epstein-Barr virus lytic switch activator ZTA transactivate with altered specificities. Mol. Cell. Biol. 14, 3041-3052.
17. Garner, M., and Revzin, A. (1981). A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: Application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9, 3047-3060.
18. Giot, J.-F., Mikaelian, I., Buisson, M., Manet, E., Joab, I., Nicolas, J.-C., and Sergeant, A. (1991). Transcriptional synergy and interference between the EBV transcription factors EB1 and R require both the basic region and the activation domains of EB1. Nucleic Acids Res. 19, 1251-1258.
19. Gorman, C., Moffat, L., and Howard, B. (1982). Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol. Cell. Biol. 2, 1044-1051.
20. Gutsch, D., Holley-Guthrie, E., Zhang, Q., Stein, B., Blanar, M., Baldwin, A., and Kenney, S. (1994). The bZIP transactivator of Epstein-Barr virus, BZLF-1, functionally and physically interacts with the p65 subunit of NF-γB. Mol. Cell. Biol. 14, 1939-1948.
21. Hardwick, J. M., Lieberman, P. M., and Hayward, S. D. (1988). A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J. Virol. 62, 2274-2284.
22. Holley-Guthrie, E., Quinlivan, E., Mar, E., and Kenney, S. (1990). The Epstein-Barr virus promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell specific manner. J. Virol. 64, 3753-3759.
23. Kenney, S., Holley-Guthrie, E., Mar, E. C., and Smith, M. (1989a). The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol. 63, 3878-3883.
24. Kenney, S., Holley-Guthrie, E., Quinlivan, E. B., Gutsch, D., Zhang, Q., Bender, T., Giot, J.-F., and Sergeant, A. (1992). The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells. Mol. Cell. Biol. 12, 136-146.
25. Kenney, S., Kamine, J., Holley-Guthrie, E., Lin, J., Mar, E., and Pagano, J. (1989b). The EBVBZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J. Virol. 63, 1729-1736.
26. Kieff, E. (1996). Epstein-Barr virus and its replication. In "Fields Virology" (B. N. Fields, D. M. Knipe, P. M. Howley, et al., Eds.), 3rd ed., pp. 2343-2396. Lippincott-Fiaven, Philadelphia.
27. Kouzarides, T., Packham, G., Cook, A., and Farrell, P. J. (1991). The BZLF1 protein of EBV has a coiled coil dimerization domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene 6, 195-204.
28. Laux, G., Freese, U. K., Fischer, R., Polack, A., Kofler, E., and Bornkamm, G. (1988). TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation. Virology 162, 503-507.
29. Lenardo, M. J., and Baltimore, D. (1989). NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229.
30. Li, Q. X., Young, L. S., Niedobitek, G., Dawson, C. W., Birkenbach, M., Wang, F., and Rickinson, A. B. (1992). Epstein-Barr virus infection and replication in a human epithelial cell system. Nature (London) 356, 347-350.
31. Lieberman, P. M., and Berk, A. (1990). In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J. Virol. 64, 2560-2568.
32. Lieberman, P. M., and Berk, A. (1991). The Zta transactivator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev. 5, 2441-2454.
33. Lieberman, P. M., Hardwick, J. M., Sample, J., Hayward, G. S., and Hayward, S. D. (1990). The Zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP1 and ZRE sites in target promoter and enhancer regions. J. Virol. 64, 1143-1155.
34. Packham, G., Economou, A., Rooney, C. M., Rowe, D. T., and Farrell, P. J. (1990). Structure and function of the Epstein-Barr virus BZLF1 protein. J. Virol. 64, 2110-2116.
35. Pearson, G. R., Vroman, B., Chase, B., Sculley, T., Hummel, M., and Kieff, E. (1983). Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J. Virol. 47, 193-201.
36. Quinlivan, E., Holley-Guthrie, E., Norris, M., Gutsch, D., Bachenheimer, S., and Kenney, S. (1993). Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res. 21, 1999-2007.
37. Rickinson, A. B., and Kieff, E. (1996). Epstein-Barr virus. In "Fields Virology" (B. N. Knipe, D. M. Fields, P. M. Howley, et al., Eds.), 3rd ed., pp. 2397-2446. Lippincott-Raven, Philadelphia.
38. Rooney, C., Taylor, N., Countryman, J., Jenson, H., Kolman, J., and Miller, G. (1988). Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency. Proc. Natl. Acad. Sci. USA 85, 9801-9805.
39. Rooney, C., Rowe, D., Ragot, T., and Farrell, P. (1989). The spliced BZLF1 gene of Epstein-Barr virus transactivates an early EBV promoter and induces the virus productive cycle. J. Virol. 63, 3109-3116.
40. Schepers, A., Pich, D., and Hammerschmidt, W. (1993). A transcription factor with homology to the Ap1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J. 12, 3921-3929.
41. Sista, N., Barry, C., Sampson, K., and Pagano, J. (1995). Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoid acid receptors RARa and RXRa. Nucleic Acids Res. 23, 1729-1736.
42. Sista, N., Pagano, J., Liao, W., and Kenney, S. (1993). Retinoid acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc. Natl. Acad. Sci. USA 90, 3894-3898.
43. Sixby, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., and Pagano, J. S. (1984). Epstein-Barr virus replication in oropharyngeal epithelial cells. New. Engl. J. Med. 310, 1225-1230.
44. Smith, D., and Johnson, K. (1987). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
45. Stein, B., Cogswell, P. C., and Baldwin, A. S. (1993). Functional and physical associations between NF-κB and C/EBP family members: A Rel domain-bZip interaction. Mol. Cell. Biol. 13, 3964-3974.
46. Takada, K., Shimuzu, N., Sakuma, S., and Keating, A. (1986). Transactivation of the latent Epstein-Barr virus genome after transfection of the EBV BamHI Z DNA fragment. J. Virol. 57, 1011-1022.
47. Takada, K., and Ono, Y. (1989). Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63, 445-449.
48. Tonneguzzo, F., Hayday, A. C., and Keating, A. (1986). Electric field-mediated DNA transfer: Transient and stable gene expression in human and mouse lymphoid cells. Mol. Cell. Biol. 6, 703-706.
49. Urier, G., Buisson, M., Chambar, P., and Sergeant, A. (1989). The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including Ap1 binding sites. EMBO J. 8, 1447-1453.
50. Young, L., Lau, R., Rowe, M., Niedobitek, G., Packham, G., Shanahan, F., Rowe, D., Greenspan, D., Greenspan, J., Rickinson, A., and Farrell, P. (1991). Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator in oral hairy leukoplakia. J. Virol. 65, 2868-2874.
51. Zalani, S., Holley-Guthrie, E., and Kenney, S. (1996). Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA 93, 9194-9199.
52. Zhang, Q., Gutsch, D., and Kenney, S. (1994). Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14, 1929-1938.
53. Zhang, Q., Hong, Y., Dorsky, D., Holley-Guthrie, E., Zalani, S., Elshiekh, N. A., Kiehl, A., Le, T., and Kenney, S. (1996). Functional and physical interactions between the Epstein-Barr virus (EBV) proteins, BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. J. Virol. 70, 5131-5142.
54. Zur Hausen, H., Bornkamm, G., Schmidt, R., and Hecker, E. (1979). Tumor initiators and promoters in the induction of Epstein-Barr virus. Proc. Natl. Acad. Sci. USA 76, 782-785.
55. Zur Hausen, H., Schulte-Holthauzen, H., Klein, G., Henle, G., Henle, W., Clifford, P., and Santesson, L. (1970). EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature (London) 228, 1956-1958.